Display options
Share it on

Endocr Pathol. 1995;6(3):197-206. doi: 10.1007/BF02739883.

HLA-D Antigen Expression and Langerhans' Cell Infiltrates in Thyroid Tumors.

Endocrine pathology

Simon L. Raphael, Sylvia L. Asa

Affiliations

  1. MD, PhD.

PMID: 12114740 DOI: 10.1007/BF02739883

Abstract

Papillary carcinomas (PCs) of thyroid are among the most common but least aggressive human malignancies. The factors explaining the indolence of these tumors are unknown but host-tumor immune interactions may play a role. This study was designed to determine if there is morphologic evidence of these. Frozen tissues collected from 21 PCs, 4 follicular adenomas (FAs), 4 follicular carcinomas (FCs), and 11 nodular hyperplasias (NHs) were stained immunohistochemically for HlLA-D antigens, lymphocyte, and macrophage markers; results were graded numerically. Paraffin-embedded tumors (35 PCs, 10 FAs, and 10 FCs) were stained for 5-100 protein to detect Langerhans' cells (LCs). Diffuse staining for HLA-D antigens and heavy mononuclear infiltrates were found more commonly in PCs compared to follicular neoplasms (FNs) or NHs. No consistent relationship was found between lymphocyte/macrophage infiltrates and expression of HLA-D antigens. The largest number of LCs was in PCs (median 11.8 cells/standard microscopic field [c/smf]), fewer cells were found in FA (3.7 c/smf), and the least in FC (0.05 c/smf). Features of host-tumor interaction including HLA-D expression and infiltrates with lymphocyte macrophages and LC are more strongly expressed in PC than other tumors. This may play a role in explaining their biological behavior.

References

  1. Am J Clin Pathol. 1992 Mar;97(3):426-34 - PubMed
  2. Cancer. 1985 Dec 1;56(11):2651-6 - PubMed
  3. Am J Clin Pathol. 1983 Mar;79(3):341-7 - PubMed
  4. J Clin Endocrinol Metab. 1989 Oct;69(4):832-6 - PubMed
  5. J Invest Dermatol. 1978 Jul;71(1):59-64 - PubMed
  6. Hum Immunol. 1986 Feb;15(2):220-33 - PubMed
  7. Clin Immunol Immunopathol. 1988 Aug;48(2):161-73 - PubMed
  8. Immunogenetics. 1981;12(3-4):409-13 - PubMed
  9. Cancer. 1988 Nov 1;62(9):1988-93 - PubMed
  10. Cancer. 1986 Jan 1;57(1):100-5 - PubMed
  11. Transplantation. 1984 Sep;38(3):293-8 - PubMed
  12. J Clin Endocrinol Metab. 1992 Aug;75(2):596-602 - PubMed
  13. Semin Diagn Pathol. 1985 May;2(2):90-100 - PubMed
  14. Lancet. 1983 Nov 12;2(8359):1115-9 - PubMed
  15. Surg Gynecol Obstet. 1965 Aug;121:243-52 - PubMed
  16. J Clin Endocrinol Metab. 1988 Feb;66(2):367-75 - PubMed
  17. Lancet. 1987 Jan 17;1(8525):165 - PubMed
  18. Br J Cancer. 1984 Nov;50(5):699-709 - PubMed
  19. J Endocrinol Invest. 1990 Jan;13(1):41-8 - PubMed
  20. Transplantation. 1981 Mar;31(3):151-5 - PubMed
  21. Am J Clin Pathol. 1988 Mar;89(3):295-300 - PubMed
  22. Nature. 1978 Dec 14;276(5689):711-3 - PubMed
  23. Autoimmunity. 1988;2(1):55-72 - PubMed
  24. Clin Exp Immunol. 1984 Nov;58(2):264-72 - PubMed
  25. Am J Pathol. 1985 Jul;120(1):106-11 - PubMed
  26. Br J Cancer. 1984 Feb;49(2):161-72 - PubMed
  27. J Clin Endocrinol Metab. 1989 Jan;68(1):145-9 - PubMed
  28. Acta Endocrinol (Copenh). 1986 Dec;113(4):508-13 - PubMed
  29. Pathol Annu. 1985;20 Pt 1:1-44 - PubMed
  30. Cancer. 1991 Feb 15;67(4):977-83 - PubMed
  31. Nature. 1981 Nov 5;294(5836):85-7 - PubMed
  32. Endocr Rev. 1993 Dec;14(6):729-46 - PubMed
  33. Am J Pathol. 1987 Jun;127(3):580-91 - PubMed
  34. Am J Pathol. 1985 Sep;120(3):334-43 - PubMed
  35. Metabolism. 1987 Apr;36(4):388-91 - PubMed
  36. Cancer. 1987 Feb 1;59(3):501-5 - PubMed

Publication Types